Vaginal Hysterectomy
14
3
3
4
Key Insights
Highlights
Success Rate
57% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 67/100
21.4%
3 terminated out of 14 trials
57.1%
-29.4% vs benchmark
36%
5 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (14)
Effect of Validated Skills Simulation With the Miya Model
Paracervical Injection and Opioid Use After Vaginal Hysterectomy for Prolapse
Vaginal NOTES Hysterectomy Versus Vaginal Hysterectomy
Evaluating the Efficacy and Safety of Preoperative Administration of Duloxetine for Pain Management in Women Undergoing Hysterectomy Via Vaginal Route
Vaginal Hysterectomy vs Supracervical Hysterectomy at the Time of Sacrocolpopexy
Do Patients Who Received Tranexamic Acid in Vaginal Hysterectomy Loose Les Blood, Comparing to Patients Who Did Not?
Liposomal Bupivacaine in Vaginal Hysterectomy
The Effect of Physiotherapy Treatment Following Gynaecological Surgery
Electrosurgical Unipolar Vessel Sealing in Vaginal Hysterectomy
Study Investigating Role of Unalike Patient Positioning on PROMIS Scores
Vaginal Prolapse Surgery Accompanied by Mid Urethral Sling Versus no Sling for Reduction of Postoperative Incontinence
Sedation With Dexmedetomidine Versus Remifentanil in Urogynecological Surgery Under Spinal Anaesthesia
0.05 Versus 0.1 mg Spinal Morphine for Reducing Morphine Requirement After Vaginal Hysterectomy
Are Sutures Required for Vaginal Hysterectomy: A Randomized Controlled Trial